Background

What do we already know about this topic?

• Achieving optimal control on a large scale has major implications for population and economic health, yet fewer than 50% of people with diabetes meet glycemic targets.1,2
• With COVID-19, implementing alternative models of care cycles has become the norm.
• In 2018, the Endocrine Society convened a taskforce to examine and promote innovative models of care in diabetes.
• In this paper, the taskforce outline models with the potential to become standards of care for both type 1 and 2 diabetes in the new normal.